IE914452A1 - 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline¹having pharmaceutical activity - Google Patents

2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline¹having pharmaceutical activity

Info

Publication number
IE914452A1
IE914452A1 IE445291A IE445291A IE914452A1 IE 914452 A1 IE914452 A1 IE 914452A1 IE 445291 A IE445291 A IE 445291A IE 445291 A IE445291 A IE 445291A IE 914452 A1 IE914452 A1 IE 914452A1
Authority
IE
Ireland
Prior art keywords
compound
oxo
dichloro
preparation
dihydro
Prior art date
Application number
IE445291A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IE914452A1 publication Critical patent/IE914452A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C07C233/15—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
IE445291A 1990-12-20 1991-12-19 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline¹having pharmaceutical activity IE914452A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63113990A 1990-12-20 1990-12-20

Publications (1)

Publication Number Publication Date
IE914452A1 true IE914452A1 (en) 1992-07-01

Family

ID=24529936

Family Applications (1)

Application Number Title Priority Date Filing Date
IE445291A IE914452A1 (en) 1990-12-20 1991-12-19 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline¹having pharmaceutical activity

Country Status (6)

Country Link
AU (1) AU9049391A (es)
IE (1) IE914452A1 (es)
MX (1) MX9102701A (es)
PT (1) PT99899A (es)
WO (1) WO1992011245A1 (es)
ZA (1) ZA9110018B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334237D1 (de) * 1992-06-22 2008-09-25 State Of Oregon Through Oregon Glycinrezeptorantagonisten und ihre verwendung
FR2707643B1 (fr) * 1993-07-16 1995-08-11 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
CA2150345A1 (en) * 1993-09-28 1995-04-06 Makoto Komatsu Quinoxaline derivative as antidiabetic agent
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
ATE267176T1 (de) * 1997-09-01 2004-06-15 Kyorin Seiyaku Kk 6,7-asymmetrisch disubstituierte chinoxalincarbonsäurederivate, additionssalze davon und verfahren zur herstellung von beiden
CA2334002A1 (en) 1998-06-03 1999-12-09 Mark H. Norman N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
JP2000309586A (ja) * 1999-02-26 2000-11-07 Kyorin Pharmaceut Co Ltd ６−置換−７−ヘテロキノキサリンカルボン酸誘導体とその付加塩及びそれらの製造方法
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
EP1244670B1 (en) 1999-12-21 2006-03-08 MGI GP, Inc. Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
FR2827599A1 (fr) * 2001-07-20 2003-01-24 Neuro3D Composes derives de quinoleine et quinoxaline,preparation et utilisations
DE10153345A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
SE0302324D0 (sv) * 2003-08-28 2003-08-28 Astrazeneca Ab Novel compounds
AU2004297235A1 (en) 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
CN101983384A (zh) * 2007-11-30 2011-03-02 葛兰素史密斯克莱有限责任公司 脯氨酰羟化酶抑制剂
US20100305154A1 (en) * 2007-11-30 2010-12-02 Glaxosmithkline Llc Prolyl Hydroxylase Inhibitors
US8889683B2 (en) * 2010-09-27 2014-11-18 Merck Sharp & Dohme Corp. Substituted quinoxalines as inhibitors of fatty acid binding protein
RU2744429C1 (ru) * 2020-05-02 2021-03-09 Андрей Александрович Иващенко Противо-РНК вирусное, в том числе противокоронавирусное средство - замещенный хиноксалин, фармацевтическая композиция и применения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
GR72941B (es) * 1978-10-20 1984-01-16 Lilly Co Eli
US4252954A (en) * 1979-10-25 1981-02-24 Eli Lilly And Company Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines

Also Published As

Publication number Publication date
ZA9110018B (en) 1993-06-21
MX9102701A (es) 1992-06-01
AU9049391A (en) 1992-07-22
WO1992011245A1 (en) 1992-07-09
PT99899A (pt) 1993-01-29

Similar Documents

Publication Publication Date Title
IE914452A1 (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline¹having pharmaceutical activity
US5284862A (en) Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) Substituted 2-carboxylindoles having pharmaceutical activity
US6124285A (en) Indole-2,3-dione-3-oxime derivatives
EP0503349B1 (en) Hydrazone derivatives, their preparation and use
US20030130278A1 (en) Alkynylated fused ring pyrimidine compounds
KR20080087070A (ko) 피리미딘 또는 트리아진 융합된 비시클릭 메탈로프로테아제억제제
CA2129214A1 (en) 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives
JPH11501640A (ja) ５−ｈｔ▲下４▼拮抗作用を有するジ−置換１，４−ピペリジンエステル類及びアミド類
EP0698025B1 (en) Ampa antagonists and a method of treatment therewith
JPS61112060A (ja) ピペラジン化合物
CA2569088C (en) Pyrrolobenzimidazolones and their use as antiproliferative agents
US7595336B2 (en) Isatine derivatives with neurotrophic activity
JPH11512728A (ja) Ｎｍｄａアンタゴニストとしてのテトラヒドロキノリン
EP0900799A1 (en) Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
EP0781285B1 (en) Fused indole and quinoxaline derivatives, their preparation and use as glutamate antagonists
EP1066037B1 (en) Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
JPH08143565A (ja) ベンズアミド化合物
US5843945A (en) AMPA antagonists and a method of treatment
US5917053A (en) Indole-2,3-dione-3-oxime derivatives, their preparation and use
JPH07324084A (ja) オキソピリジニルキノキサリン誘導体

Legal Events

Date Code Title Description
FC9A Application refused sect. 31(1)